IntelliPharmaCeutics International Inc (IPCIF)
0.10
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
IntelliPharmaCeutics International Price: 0.10 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 0.10 | 0.10 | 0.10 | 0.10 | 216.00 |
May 09, 2024 | 0.10 | 0.10 | 0.10 | 0.10 | 0.000 |
May 08, 2024 | 0.08 | 0.10 | 0.08 | 0.10 | 2065.00 |
May 07, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 0.000 |
May 06, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 100.00 |
May 03, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 0.000 |
May 02, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 0.000 |
May 01, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 601.00 |
Apr 30, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 0.000 |
Apr 29, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 100001.0 |
Apr 26, 2024 | 0.075 | 0.075 | 0.06 | 0.06 | 7501.00 |
Apr 25, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 724.00 |
Apr 24, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 0.000 |
Apr 23, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 100.00 |
Apr 22, 2024 | 0.06 | 0.12 | 0.06 | 0.12 | 2816.00 |
Apr 19, 2024 | 0.09 | 0.09 | 0.06 | 0.06 | 10175.00 |
Apr 18, 2024 | 0.1075 | 0.1075 | 0.07 | 0.07 | 4177.00 |
Apr 17, 2024 | 0.135 | 0.135 | 0.135 | 0.135 | 0.000 |
Apr 16, 2024 | 0.06 | 0.135 | 0.06 | 0.135 | 16300.00 |
Apr 15, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 0.000 |
Apr 12, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 10000.00 |
Apr 11, 2024 | 0.0705 | 0.0705 | 0.0705 | 0.0705 | 0.000 |
Apr 10, 2024 | 0.0705 | 0.0705 | 0.0705 | 0.0705 | 0.000 |
Apr 09, 2024 | 0.06 | 0.0705 | 0.06 | 0.0705 | 2921.00 |
Apr 08, 2024 | 0.0724 | 0.0724 | 0.0724 | 0.0724 | 2085.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.0012
Minimum
May 09 2023
0.92
Maximum
Jan 03 2020
0.1351
Average
0.13
Median
Oct 31 2019
Price Benchmarks
Acasti Pharma Inc | 2.76 |
Aurinia Pharmaceuticals Inc | 5.02 |
Edesa Biotech Inc | 4.61 |
Lexaria Bioscience Corp | 3.55 |
Xenon Pharmaceuticals Inc | 40.54 |
Price Related Metrics
PS Ratio | 4.061 |
Price to Free Cash Flow | 30.51 |
Earnings Yield | -92.00% |
Market Cap | 3.309M |